Kayatas, KadrKaya, OzhanSenates, EbubekrYesil, AtakanSenates, Banu ErkalmaYesil, Ezgi ErsoyBelen, Erdal2024-04-242024-04-2420140393-6384https://hdl.handle.net/11468/23023Background/Aim: The relationship between dyslipidemia and various malignancies is still unclear. We therefore investigated the possible relationship between atherogenic dyslipidaemia and colon polyps and assessed the predictive role of dyslipidaemia in the development of colorectal cancer. Methods: The study involved patients evaluated at the Gastroenterology Clinic of HaydarpasaNumune Training and Research Hospital between October 2, 2011, and November 16, 2012. Data were collected from 74 patients with colon polyps (advanced and low-grade dysplasia [LGD]) and 57 healthy control subjects. Results: Triglyceride (p=0.001) and high-density lipoprotein (HDL)-cholesterol (p<0.01) concentrations were significantly higher in patients with advanced dysplasia (AD) than in the control group. Triglyceride (p=0.001) and HDL-cholesterol (p<0.01) concentrations were also significantly higher in patients with LGD than in the control group. Triglyceride and HDL-cholesterol concentrations, however, were similar in the AD and LGD groups. Conclusions: Atherogenic dyslipidaenzia is significantly associated with adenoma, suggesting that it could be involved in adenoma development. Atherogenic dyslipidaemia should not be ignored in colorectal cancer prevention programs.eninfo:eu-repo/semantics/closedAccessPolypsDyslipidaemiaTriglycerideArticle3015762WOS:000335937700007Q4